Sepsis Diagnostics Market Growth Drivers and Challenges:
Growth Drivers
- Growing Prevalence of Hospital-Acquired Infections – Hospital-acquired infections (HAIs), also known as nosocomial infections, are a major cause of morbidity and mortality worldwide. Urinary tract infections, pneumonia, and sepsis are the most frequent Hospital Acquired Infections. HAIs can lead to sepsis in immunocompromised patients, geriatric patients, and patients suffering from chronic illnesses. For instance, in the United States, there is an increase in sepsis by 8.7% annually among patients admitted to a hospital. It is estimated that more than 1,000,000 cases of sepsis among hospitalized patients occur each year in the United States.
- Development of Rapid Diagnostic Techniques for Sepsis Diagnosis – Sepsis is a very difficult condition to diagnose and the risk of mortality increases by 7.6%. Therefore, there is an increasing need to develop diagnostic tools for sepsis. Hence, the BACTEC Plus and BACTEC FX blood culturing instruments manufactured by BD Company (US) an automated microbial detection system offering a rapid diagnosis of sepsis in a turnaround time of three hours. Increase in Funding for Sepsis-Related Research Activities – According to the most recent reports, sepsis funding and directives have been included in the USD 1.7 trillion Omnibus spending bill passed and signed by President Joe Biden in January 2023. It is predicted that this boom would continue over the forecast period.
- Increasing Burden of Sepsis – the global sepsis mortality rate is reported as 11 million in the year 2019. Reports from WHO cite that 85% of sepsis cases occur in low and middle-income countries. This increasing burden of sepsis is hence expected to contribute to the growth of the market in the forecast period.
Challenges
- High cost of diagnostic devices - The increasing concern amongst people about the high cost of diagnostic devices is one of the major factors predicted to slow down the market growth. The cost of molecular diagnostic tests is between USD 300 and USD 3,000, which is very high compared to the cost of blood culture tests priced as low as ~USD 28–35.
- Shortage of skilled healthcare professionals
- Lack of appropriate testing for sepsis
Sepsis Diagnostics Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
8.3% |
|
Base Year Market Size (2025) |
USD 927.77 million |
|
Forecast Year Market Size (2035) |
USD 2.06 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of sepsis diagnostics is estimated at USD 997.07 million.
The global sepsis diagnostics market size was more than USD 927.77 million in 2025 and is anticipated to grow at a CAGR of over 8.3%, reaching USD 2.06 billion revenue by 2035.
The North America sepsis diagnostics market is forecasted to hold a 39% share by 2035, driven by advanced healthcare infrastructure, high presence of key players, and a strong reimbursement framework.
Key players in the market include BioMérieux SA, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche AG, Danaher Corporation (Beckman Coulter, Inc.), Cepheid, Beckman Coulter, Inc., Amara Health Analytics, Wolters Kluwer N.V., Cerner Corp.
